A Review of the Clinical Uses of Ximelagatran in Thrombosis Syndromes


Ximelagatran, an oral direct thrombin inhibitor, has been investigated for the prevention and treatment of venous thromboembolism as well as for anticoagulation in atrial fibrillation. Unique properties of ximelagatran are that it is a prodrug, it does not require routine laboratory monitoring and it has minimal drug interactions. The dose of ximelagatran… (More)
DOI: 10.1023/B:THRO.0000024056.84909.b0


5 Figures and Tables